ADCY3
|
Adenylate cyclase 3 |
2p23.3 |
Severe-early onset |
Type 2 diabetes |
Tian et al. 2018 [10] |
BDNF
|
Brain-derived neurotrophic factor |
11p14.1 |
Severe-early onset |
Hyperphagia, severe obesity, hyperactivity and impaired cognitive function. |
Han et al. 2016 [11] |
KSR2
|
Kinase suppressor of ras 2 |
12q24.22-q24.23 |
Severe |
Hyperphagia (in childhood), insulin resistance and reduced basal metabolic rate. |
Frodyma et al. 2017 [12] |
LEP
|
Leptin |
7q32.1 |
Severe, early onset |
Hyperphagia, hypogonadotropic hypogonadism. Some evidence for neuroendocrine/metabolic and immune dysfunction |
Wasim et al 2016; Yeo 2017 [13, 14] |
LEPR
|
Leptin receptor |
1p31.3 |
Severe, early onset |
Hyperphagia, hypogonadotropic hypogonadism. Some evidence for neuroendocrine/metabolic and immune dysfunction |
Wasim et al 2016; Yeo 2017 [13, 14] |
MC4R
|
Melanocortin 4 receptor |
18q21.32 |
Severe, early onset |
Increased linear growth and final height, fasting hyperinsulinemia and incompletely suppressed growth hormone secretion. |
Krashes et al 2016; Yeo 2017; Novoselova et al 2018 [14–16] |
PCSK1
|
Proprotein convertase subtilisin/kexin type 1 |
5q15 |
Severe – occurring in childhood |
Hyperphagia, impaired glucose homeostasis, decreased linear growth, hypothyroidism, hypocortisolism and hypogonadotropic hypogonadism |
Ramos-Molina et al 2016; Stijnen et al 2016 [17, 18] |
POMC
|
Proopiomelanocortin |
2p23.3 |
Severe, from the first months |
Adrenocorticotropic hormone (ACTH) deficiency, red hair and pale skin |
Anderson et al 2016; Rubinstein and Low 2017 [19, 20] |